India, June 30 -- Oxford BioDynamics Plc OBD.L, a biotechnology company, on Tuesday reported financial results for the six months ending March 31, 2026.
The company specializes in developing precision clinical diagnostic tests and a genomics platform.
Following the announcement, shares fell over 30% in Tuesday's trade.
Half Year 2026:
The company reported a net loss of £4.46 million or 0.1p per share, lower than the net loss of £5.75 million or 0.7p per share in 2025. The lower loss can be attributed to higher revenues and a resulting higher gross profit in the half year.Revenues for the first quarter reached £0.69 million, an increase from the £0.59 million recorded in the half year a year ago.
Cash, cash equivalen...